iRhythm Technologies (IRTC)
(Delayed Data from NSDQ)
$116.43 USD
+0.09 (0.08%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $116.48 +0.05 (0.04%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
IRTC 116.43 +0.09(0.08%)
Will IRTC be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for IRTC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IRTC
iRhythm Technologies (IRTC) Surges 4.2%: Is This an Indication of Further Gains?
IRhythm Technologies (IRTC) Reports Q4 Loss, Tops Revenue Estimates
IRTC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Inspire Medical Systems (INSP) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Down -23.87% in 4 Weeks, Here's Why iRhythm Technologies (IRTC) Looks Ripe for a Turnaround
IRhythm Technologies (IRTC) Expected to Beat Earnings Estimates: Should You Buy?
Other News for IRTC
Baron Health Care Fund Q1 2024 Shareholder Letter
iRhythm Technologies to Report First Quarter 2024 Financial Results on May 2, 2024
Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down
Class Action Suit against iRhythm Technologies, Inc. (IRTC)
What's Driving LivaNova PLC's Surprising 11% Stock Rally?